Updates are available Correction dated 2020-11-24
Click to view Correction: https://doi.org/10.1038/s41551-020-00664-y
-
Authors
Saif, Mari
Kwanten, Wilhelmus J. http://orcid.org/0000-0001-9474-6695
Carr, Jessica A.
Chen, Ivy X.
Posada, Jessica M.
Srivastava, Amitabh
Zhang, Juanye
Zheng, Yi
Pinter, Matthias
Chatterjee, Sampurna
Softic, Samir
Kahn, C. Ronald
van Leyen, Klaus
Bruns, Oliver T.
Jain, Rakesh K. http://orcid.org/0000-0001-7571-3548
Bawendi, Moungi G. http://orcid.org/0000-0003-2220-4365
- License Information
-
More Information
Article History
Received: 21 June 2019
Accepted: 13 May 2020
First Online: 22 June 2020
Change Date: 12 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-020-00664-y
Competing interests
: M.P. is an investigator for Bayer, BMS and Lilly; a consultant for Bayer, BMS, Ipsen, Eisai and Lilly; and has received speaker honoraria from Bayer, BMS, Eisai and MSD as well as travel support from Bayer and BMS. R.K.J. received honorarium from Amgen; consultant fees from Chugai, Merck, Ophthotech, Pfizer, SPARC, SynDevRx and XTuit; owns equity in Enlight, Ophthotech, SynDevRx; and serves on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. M.G.B. is a consultant and owns equity in Lumicell Inc. Neither any reagent nor any funding from these organizations was used in this study. MIT and MGH have filed a patent (United States application no. 62/654,665; international application no. PCT/US2019/026550) based on some of the findings described in this manuscript.
